nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biosimilars: Extrapolation for oncology
|
Curigliano, Giuseppe |
|
2016 |
104 |
C |
p. 131-137 7 p. |
artikel |
2 |
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program
|
Zinzani, P.L. |
|
2016 |
104 |
C |
p. 65-70 6 p. |
artikel |
3 |
Chronic lymphocytic leukaemia
|
Scarfò, Lydia |
|
2016 |
104 |
C |
p. 169-182 14 p. |
artikel |
4 |
Editorial Board
|
|
|
2016 |
104 |
C |
p. IFC- 1 p. |
artikel |
5 |
Endoscopic mucosal resection and endoscopic submucosal dissection for colorectal lesions: A systematic review
|
De Ceglie, Antonella |
|
2016 |
104 |
C |
p. 138-155 18 p. |
artikel |
6 |
Human epidermal growth factor antagonists and cardiotoxicity—A short review of the problem and preventative measures
|
Dias, A. |
|
2016 |
104 |
C |
p. 42-51 10 p. |
artikel |
7 |
Integrated scientific data bases review on asulacrine and associated toxicity
|
Afzal, Attia |
|
2016 |
104 |
C |
p. 78-86 9 p. |
artikel |
8 |
Kaposiform haemangioendothelioma of the head and neck
|
Wong, Billy L.K. |
|
2016 |
104 |
C |
p. 156-168 13 p. |
artikel |
9 |
Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials
|
Tamburini, Emiliano |
|
2016 |
104 |
C |
p. 115-123 9 p. |
artikel |
10 |
Management of hemopoietic neoplasias during pregnancy
|
Paydas, Semra |
|
2016 |
104 |
C |
p. 52-64 13 p. |
artikel |
11 |
MicroRNA-1 properties in cancer regulatory networks and tumor biology
|
Weiss, Martin |
|
2016 |
104 |
C |
p. 71-77 7 p. |
artikel |
12 |
Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas
|
Helfferich, Jelte |
|
2016 |
104 |
C |
p. 30-41 12 p. |
artikel |
13 |
Principles of genetic variations and molecular diseases: applications in hemophilia A
|
Lannoy, N. |
|
2016 |
104 |
C |
p. 1-8 8 p. |
artikel |
14 |
Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients
|
Meghelli, Leila |
|
2016 |
104 |
C |
p. 108-114 7 p. |
artikel |
15 |
Review on TAS-102 development and its use for metastatic colorectal cancer
|
Mota, Jose Mauricio |
|
2016 |
104 |
C |
p. 91-97 7 p. |
artikel |
16 |
Targeting Notch degradation system provides promise for breast cancer therapeutics
|
Liu, Jing |
|
2016 |
104 |
C |
p. 21-29 9 p. |
artikel |
17 |
Therapeutic potential and critical analysis of trastuzumab and bevacizumab in combination with different chemotherapeutic agents against metastatic breast/colorectal cancer affecting various endpoints
|
Wahid, Mohd |
|
2016 |
104 |
C |
p. 124-130 7 p. |
artikel |
18 |
The role of aspirin in colorectal cancer chemoprevention
|
Singh Ranger, Gurpreet |
|
2016 |
104 |
C |
p. 87-90 4 p. |
artikel |
19 |
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations
|
Novello, S. |
|
2016 |
104 |
C |
p. 9-20 12 p. |
artikel |
20 |
Understanding the biosimilar approval and extrapolation process—A case study of an epoetin biosimilar
|
Agarwal, Amit B. |
|
2016 |
104 |
C |
p. 98-107 10 p. |
artikel |